New Delhi [India], June 14: The Fondazione Ricerca e Innovazione Cardiovascolare (RIC) has successfully finished patient enrolment for TRANSFORM II, one of the most ambitious and extensive randomised controlled trials (RCTs) ever carried out in the field of cardiovascular care, at a pivotal point for the future of interventional cardiology.
Saturday, June 14
Trending
- BillWizz: Revolutionizing Online Bill Payments for Indians
- Vantage Announces Continued Global Commitment to Safe, Transparent Trading Access
- TRANSFORM II Trial Hits Enrollment Milestone: Redefining Coronary Care with Sirolimus-Coated Balloons
- Covero and FashionCart: Changing Online Shopping in India
- Woh Kahani’s Journey of Sound: Where Every Word Speaks
- JPrime Buildcon’s Grand Business Meet ‘Sankalp 2025’ Marks a New Chapter in Mumbai 3.0 Growth Story
- Famous writer Chetan Bhagat Launches World of Basalt Reinforcement by Mahesh Kumar Jogani
- Introducing Hidoc Dr KOL Factory The Future Hub for Oncology Leaders Worldwide
Health
In the vibrant streets of Vikaspuri, Delhi, a guiding light in the realm of holistic…
New Delhi (India), April 23: The 7th Annual Consensus Conference on MGB/OAGB (Mini Gastric Bypass/One…
Planning to launch more VASU outlets in major cities of Gujarat – Ahmedabad, Surat, Rajkot…
Dr. Radhika Gupta, founder of the ‘Dr. Radhika Gupta Dental & Aesthetic Clinic’ , is…
Dr. Megha Nagpal is an acclaimed facial aesthetician, whose expertise has made her a sought-after…
• Inauguration of Gujarat’s First Robotic Hip & Knee Replacement Centre at Nirali Hospital…
© 2025 PNN Digital. Designed by Primex Media Services.